(# co-first author, * correspondence)
2024
Su J#, Xiao Y#, Wang X, Zheng J*, Wang JZ*. Development of tau phosphorylation-targeting therapies for the treatment of neurodegenerative diseases. Medicine Plus. 2024. In Press. doi: 10.1016/j.medp.2024.100060. Review
Xiao Y#, Wei L#, Su J#, Lei H, Sun F, Li M, Li S, Wang X*, Zheng J*, Wang JZ*. A tau dephosphorylation-targeting chimera selectively recruits protein phosphatase-1 to ameliorate Alzheimer's disease and tauopathies. Cell Chem Biol. 2024. 31(10):1787-1799.e6.
Qi X#, Yuan S#, Ding J#, Sun W, Shi Y, Xing Y, Liu Z, Yao Y, Fu S, Sun B, Qi X, Xia B, Liu F, Yi M, Mao J, Wan Y*, Zheng J*. Emerging signs of Alzheimer-like tau hyperphosphorylation and neuroinflammation in the brain post recovery from COVID-19. Aging Cell. 2024. 23(11):e14352
Su J#, Xiao Y#, Wei L, Lei H, Sun F, Wang W, Li S, Wang X*, Zheng J*, Wang JZ*. A new tau dephosphorylation-targeting chimera for the treatment of tauopathies. Acta Pharmacol Sin. 2024. 45(11):2267-2276
Su J#, Xiao Y#, Wei L, Lei H, Sun F, Wang W, Yin J, Xiong R, Li S, Zhang P, Zhou Y, Wang X*, Zheng J*, Wang JZ*. Generation of tau dephosphorylation-targeting chimeras for the treatment of Alzheimer's disease and related tauopathies. Sci Bull (Beijing). 2024. 69(8):1137-1152.
2023
Gao Y#*, Wang YY#, Lei HY, Xu ZD, Li SH, Yu HT, Xie JZ, Zhang ZT, Liu GP, Zhang Y*, Zheng J*, Wang JZ*. A novel transgenic mouse line with hippocampus-dominant and inducible expression of truncated human tau. Transl Neurodegener. 2023. 12(1), 51.
Gao Y#, Yu H#, Liu Y, Xu Z, He B, Liu H, Wang Y, Zhang Y, Liang Y, Yang Y, Zheng J*, Wang JZ*. GSK-3β activation mediates apolipoprotein E4-associated cognitive impairment in type 2 diabetes mellitus: A multicenter, cross-sectional study. J Diabetes. 2023. 16(1):e13470.
Shi Y, Wan Y, Zheng J*. Waking up neural stem cells through inhibition of mitochondrial pyruvate import. Brain‐X. 2023. 1(2).e13. Commentary
2022
2021
Zheng J#*, Tian N#, Liu F, Zhang Y, Su J, Gao Y, Deng M, Wei L, Ye J, Li H, Wang JZ*. A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies. Signal Transduct Target Ther. 2021. 6(1):269. (Cover story)
Zheng J*, Li Y. Compensation for Neurodegeneration by Hippocampal Neurogenesis in Alzheimer's Disease: Where is the Way? Neurosci Bull. 2021. 37(6):885-888. Insight
2020
Zheng J#*, Li HL#, Tian N, Liu F, Wang L, Yin YL, Yue LP, Ma LY, Wan Y, Wang JZ*. Interneuron accumulation of phosphorylated tau impairs adult hippocampal neurogenesis by suppressing GABAergic transmission. Cell Stem Cell. 2020. 26(3):331-345.e6.
Liu F, Tian Na, Zhang HQ, Li SH, Zhou QZ, Zheng J*, Wang JZ*. GSK-3β activation accelerates early-stage consumption of hippocampal neurogenesis in senescent mice. Theranostics. 2020. 10(21):9674-9685.
2017
Zheng J, Jiang YY, Ma LY, Liu FY, Cui S, Cai J, Liao FF, Wan Y*, Yi M*. Adult hippocampal neurogenesis along the dorsoventral axis contributes differentially to environmental enrichment combined with voluntary exercise in alleviating chronic inflammatory pain in mice. J Neurosci. 2017. 37(15):4145-4157.
Zheng J, Yi M, Wan Y*. Hippocampal neurogenesis: does it relieve or worsen chronic pain? Pain. 2016. 157(2):506-507. Letter to editor
